Arizona Tribune - Boulevard

NYSE - LSE

RBGPF	0.33%	61.5	$
CMSD	0.59%	21.9	$
CMSC	0.59%	22.06	$
RYCEF	0%	18.75	$
BCC	-2.22%	79.26	$
RIO	0.58%	94.29	$
BCE	-2.96%	22.26	$
GSK	0.59%	52.81	$
RELX	-0.16%	31.29	$
AZN	1.33%	190.95	$
JRI	0.54%	12.86	$
VOD	-1.46%	13.69	$
BTI	-0.03%	62.74	$
BP	0.59%	37.35	$
NGG	0.9%	83.76	$

Featured

Shooter in custody dispute kills six at German family shelter

A gunman locked in a custody battle over his three-month-old daughter killed six people Monday at a German shelter for mothers and their children in the northern town of Stade, police said.

US races to reopen Venezuela port as quake deaths top 1,700

The US military raced to reopen a major port in Venezuela to ease aid deliveries on Monday as the deaths from last week's twin earthquakes reached more than 1,700 with tens of thousands still reported missing.

Last news

Swedish police say school killing spree gunman likely shot himself

Swedish police indicated Wednesday that a gunman who slaughtered 10 people at an adult education centre shot himself as the country mourned its worst mass killing.

Sweden reels from worst mass shooting in its history

Sweden on Wednesday was recovering from the deadliest mass shooting in its history after 10 people -- as well as the suspected gunman -- were killed at an education centre in the city of Orebro, with many questions still unanswered.

Blackbox Press Event and Regional Government Roundtable

It being our first event, we began by explaining Blackbox's mission statement and the social context that led to our launch. General Manager Taiki Iwasaki talked about the growing support for startups - especially foreign startups - in Japan over the last few years.

Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

DENVER, CO / ACCESS Newswire / February 5, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its operational and financial results for its second quarter of fiscal 2025, after the market close on Wednesday, February 12, 2025. The Company has scheduled a conference call and webcast that same day, Wednesday, February 12, 2025, at 4:30 p.m. Eastern time, to review the results followed by a question and answer session.

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

Revenues increased 14% for the quarter compared to prior year and 13% year-to-datePositive cash flow from operations for the quarter with $5.2 million of cash at December 31, 2024Year-to-date net loss decline of $1.1 million

Registration Now Open for World of Coffee 2025 in Geneva: The Premier Event for Coffee Professionals

Join Over 13,000 Attendees and 430+ Exhibitors at Europe's Largest Specialty Coffee Trade Show

Clover Sonoma(R) Unveils Pasture Raised Organic A2 4% Whole Milk

"We're thrilled to introduce A2 milk as a potential solution for those who struggle to digest dairy products," said Clover Sonoma Chief Executive Officer John Coletta. "It matters where your dairy comes from, which is why we proudly partner with local Northern California family farms raising Jersey and Guernsey cows that naturally produce the A2 protein."

As Valentine’s Day Approaches, Bestselling Memoir Encourages Self-Love as Key to Thriving Relationships, Life

DENVER, CO / ACCESS Newswire / February 5, 2025 / What happens when 'I do' becomes 'I don't'? Love is in the air with Valentine's Day around the corner, but this bestselling author encourages women to reflect inward and seek self-love first.

Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market

CHICAGO, IL / ACCESS Newswire / February 5, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the filing of a patent application for multiple sclerosis (MS), a disabling autoimmune disorder affecting millions worldwide.

Church of Ambrosia Joins Forces with the Oakland Hyphae for the 5th Annual Spirituality and Beyond - April 19th and 20th, 2025

OAKLAND, CA / ACCESS Newswire / February 5, 2025 / A groundbreaking spiritual and psychedelic gathering is coming to the San Francisco Bay Area on Bicycle Day (4/19) and 4/20. This year, Easter Sunday coincides with 4/20, adding an extra layer of significance to this once-in-a-lifetime experience. The Church of Ambrosia, the world's largest psychedelic church with over 120,000 members, is merging its annual Easter celebration, Spirituality and Beyond, with the Oakland Psychedelic Conference for an unprecedented two-day event.

CORRECTING AND REPLACING: HydraPatch(R) & Zoot Sports Announce Partnership

NORTH BRUNSWICK, NJ / ACCESS Newswire / February 5, 2025 / HydraPatch® and Zoot Sports have entered a partnership, to assist triathletes of all skill levels with managing their hydration levels and recovery efforts.

Lexaria Updates its Ongoing Human Study GLP-1-H24-4

Registered Phase-1b 12-week study investigating safety, diabetes control, and weight loss

The Icon in Culinary Arts - Chef Alan Coxon, Challanges the Stigma Surrounding the Taste of Collagen Peptides

Chef Alan Coxon, an Icon in the Culinary Arts, Sets a New Standard by Partnering With Enchant Brands, an Innovator in Nutrition Powders, to Challenge and Redefine the Stigma Surrounding the Taste of Collagen Peptides.

CV Sciences Unveils New Aura Collection THC Fizz Tablets

The innovative, lemon-flavored fast-acting tablets provide a quick, uplifting experience, perfect for enhancing social moments or relaxing at home.

Deep Blue Sports + Entertainment Announces Joint Venture With Always Alpha, Creating Women's Sports' First Full-Service Management Offering

Always Alpha co-founders Allyson Felix and CEO Cosette Chaput join forces with Deep Blue's founder and CEO Laura Correnti to elevate the women's sports industry by creating the largest firm and first one-stop shop dedicated exclusively to women's sports

Jerash Holdings (US), Inc. Declares Quarterly Dividend

FAIRFIELD, NJ / ACCESS Newswire / February 5, 2025 / Jerash Holdings (US), Inc. (NASDAQ:JRSH) (the "Company" or "Jerash"), which manufactures and exports custom, ready-made, sportswear and outerwear for leading global brands, announced today that its board of directors approved the payment of a regular quarterly dividend of $0.05 per share on the Company's common stock. The dividend is payable on or about February 25, 2025 to the stockholders of record as of February 18, 2025.

Ensysce Biosciences Reports Continued Positive Progress in Groundbreaking Trial on PF614-MPAR, Comments on Current Landscape for Pain Treatment

~ Positive Enrollment Progress and Safety Data ~~ FDA Attention Establishes Momentum in the Pain Treatment Space ~

Polaris Renewable Energy Declares Quarterly Dividend

TORONTO, ON / ACCESS Newswire / February 5, 2025 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to announce that its board of directors has declared a quarterly dividend of US$0.15 per common share outstanding.

CTT Pharma Adds Independent Director With NIH/NSF Experience

TAMPA, FL / ACCESS Newswire / February 5, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC PINK:CTTH) is pleased to announce adding Dr. Katherine Cole as an Independent Director for CTT. Dr. Cole. a Ph.D. in Pathology from the University of Maryland School of Medicine. Following her Ph.D. she spent 3 years at the National Cancer Institute(NCI) at the National Institutes of Health(NIH) where she spent her time focused on anti-cancer mechanisms of novel chemotherapeutic compounds. From there Dr. Cole worked at four different universities as a Biomedical scientist, professor, and eventually as a vice Provost and Dean. She has published twenty-two peer reviewed papers and has been granted two patents related to a human liver cell line. Dr. Cole has been awarded many notable grants including grants from the National Science Foundation(NSF) and the Howard Hughes Medical Institute. Dr. Cole's professional development as a scientist, an educator and a university-level administrator has provided her with a distinct scientific perspective and an ability to critically analyze meaningful data and research design. Her Ph.D. in Pathology from the University of Maryland School of Medicine and postdoctoral experience at the NIH/NCI in cancer research have positioned her well to not only understand the science behind this technology, but the impact from a human pathological perspective. CTT is honored to have Dr. Cole on our team and looks forward to her contributions.

Forte Group Appoints Dallas Pretty as Chief Financial Officer

VANCOUVER, BC / ACCESS Newswire / February 5, 2025 / Forte Group Holdings Inc. (CSE:FGH)(OTC PINK:FGHFF)(FSE:7BC0, WKN:A40L1Z)("Forte Group" or the "Company"), a diversified lifestyle and wellness consumer packaged goods company, announces the appointment of Dallas Pretty, CPA, CA, as its Chief Financial Officer and Corporate Secretary, effective February 4, 2025. Mr. Pretty succeeds John Campbell, who has resigned from his roles as Chief Financial Officer, Chief Strategy Officer, and Corporate Secretary effective February 4, 2025.

Reservoir Media Announces Third Quarter Fiscal 2025 Results

Strong Results in Both Segments Grew Total Revenue by 19% Including AcquisitionsKey Catalog Additions and Disciplined Cost Controls Drive Margin GrowthRaises Fiscal 2025 Financial Outlook

'Bodies on the ground': mass shooting shocks Sweden's Orebro

Linn could not get the thought of "blood everywhere" out of her head after her usually quiet town of Orebro on Tuesday became the scene of the worst mass shooting in Swedish history.

'Around 10' dead, including gunman, in Sweden's worst mass shooting

Around 10 people were killed on Tuesday in a shooting at an education centre in Sweden, including the suspected gunman, with the Swedish prime minister branding it the "worst mass shooting" in the country's history.

'Around 10' dead, including shooter, in Sweden campus attack

Around 10 people were killed Tuesday in a shooting at an education centre in Sweden, including the suspected gunman, police said after the rare gun attack on a campus in the Nordic nation.

Attempted murder trial of Rushdie assailant opens

The trial of the man accused of attempting to kill Salman Rushdie in 2022, leaving the famed author blind in one eye, opened Tuesday with jury selection.

Gunman wounds four at Sweden education centre

A gunman shot and wounded four people at an education centre in central Sweden on Tuesday, police said, urging the public to stay away from the area as officers hunted for possible accomplices.

Thousands leave as fresh tremors shake Greece's Santorini

Thousands of people fled the Greek island of Santorini by sea and air for a third day on Tuesday, as more earthquakes shook the top travel destination.

Lack of regional cooperation hampering Lake Chad jihadist fight

Lack of military coordination and tension among countries in Africa's Lake Chad region are hindering efforts to end a more than decade-long jihadist insurgency, according to local officials and security sources.

Police officer 'determined' to pursue prosecution of Chelsea star Kerr

A police officer told a London court on Tuesday that he was determined to pursue the prosecution of Chelsea and Australia football star Sam Kerr after she called him "stupid and white".

Frenchman on death row in Indonesia since 2007 leaves for Paris

A Frenchman on death row in Indonesia since 2007 for drug offences left for France on Tuesday, with his lawyer saying he was "happy and calm" ahead of returning home.

Five people wounded in Sweden school shooting

Five people were shot and wounded at a school in the central Swedish city of Orebro on Tuesday, police said, urging the public to stay away from the area as a large operation was underway.

Ferrari reports another record-breaking year

Italian luxury carmaker Ferrari posted another set of record results on Tuesday, with net profit surging to more than 1.5 billion euros last year.

Arizona Tribune - Boulevard (English)